RBF Capital’s Kezar Life Sciences KZR Stock Holding History

RBF Capital’s Portfolio KZR Stock Details KZR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$209K	Hold	28,144	–	–	0.01%	457
2025 Q4	$177K	Sell	28,144 -109	-0.4%	-$636	0.01%	525
2025 Q3	$110K	Hold	28,253	–	–	﹤0.01%	551
2025 Q2	$129K	Hold	28,253	–	–	0.01%	556
2025 Q1	$138K	Hold	28,253	–	–	0.01%	534
2024 Q4	$190K	Buy	28,253 +1	+0%	+$7	0.01%	504
2024 Q3	$218K	Hold	28,252	–	–	0.01%	539
2024 Q2	$170K	Buy	+28,252	New	+$215K	0.01%	529
2021 Q2	–	Sell	-1,215	Closed	-$72K	–	494
2021 Q1	$72K	Sell	1,215 -4,100	-77%	-$240K	﹤0.01%	441
2020 Q4	$277K	Hold	5,315	–	–	0.02%	322
2020 Q3	$257K	Hold	5,315	–	–	0.03%	294
2020 Q2	$275K	Hold	5,315	–	–	0.03%	304
2020 Q1	$232K	Sell	5,315 -3,630	-41%	-$148K	0.03%	300
2019 Q4	$359K	Buy	+8,945	New	+$275K	0.03%	285

Other funds holding KZR

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Rangeley Capital New Canaan, Connecticut $103M AUM 77.36% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PLC

Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

RBF Capital's KZR Position: Q1 2026 in Review

RBF Capital held its Kezar Life Sciences (KZR) position steady in Q1 2026 at 28,144 shares worth $209K. The position accounts for 0.01% of the portfolio, ranked #457.

RBF Capital first reported a position in KZR in Q4 2019 and has held it in 14 quarters since. The position peaked at $359K in Q4 2019. 43 funds tracked by Wall St. Rank hold KZR as of Q1 2026.

RBF Capital held 28,144 shares of Kezar Life Sciences worth $209K as of Q1 2026.
RBF Capital left its Kezar Life Sciences share count unchanged in Q1 2026.
Kezar Life Sciences made up 0.01% of RBF Capital's portfolio in Q1 2026, its #457 holding.
RBF Capital first reported a position in Kezar Life Sciences in Q4 2019 and has held it in 14 quarters since.
RBF Capital's Kezar Life Sciences position peaked at $359K in Q4 2019.
43 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q1 2026.

Based on RBF Capital's 13F filing for Q1 2026, filed 15 May 2026.